Deliverability-aware deep learning substantially improves automated IMRT planning for lymphoma

Adding fluence supervision and cycle consistency substantially improved machine-deliverable lymphoma IMRT plans compared with dose-only deep learning.

KEY POINTS

  • The retrospective single-institution dataset contained 619 lymphoma plans from 571 patients, spanning highly heterogeneous target locations and volumes. The original clinical VMAT plans were converted into standardized 15-field coplanar 6-MV sliding-window IMRT reference plans, with 61 plans reserved for independent testing.
  • Two deep-learning approaches were compared: a conventional dose-only model and a multi-objective model combining dose supervision, fluence supervision, and dose–fluence–dose cycle consistency. Predicted fluence maps were imported directly into Eclipse, leaf-sequenced, and recalculated with AcurosXB without additional optimization or manual editing.
  • Deliverability-aware training substantially improved target coverage. Mean PTV D98 increased from 78.59% with dose-only training to 90.10%, approaching 91.62% for the TPS reference plans. The median paired D98 improvement was +12.31 percentage points (Holm-corrected p<0.0001).
  • Hotspot control also improved: mean PTV D2 decreased from 109.65% to 106.28%, while Dmax decreased from 113.27% to 110.32%. Median paired improvements were −3.43 percentage points for D2 and −3.18 percentage points for Dmax, both p<0.0001.
  • The deliverability-aware model still did not fully match the TPS reference. Compared with the reference plans, median D98 remained 1.66 percentage points lower (p=0.014), while D2 and Dmax remained 1.60 and 4.01 percentage points higher, respectively.
  • Using exploratory thresholds of D98 >90% and Dmax ≤110%, only 4.9% of dose-only plans satisfied both criteria versus 31.1% with the multi-objective model and 72.1% of TPS reference plans. Fluence-map generation remained fast at <1 second per map.
  • The ablation analysis showed that fluence supervision was the main stabilizing component: adding it alone increased mean D98 from 78.59% to 88.27%. Cycle consistency without fluence supervision actually worsened performance, whereas combining both produced the best results. Generalizability remains uncertain because the reference plans used a fixed 15-field geometry and were standardized research replans rather than individually optimized clinical plans.

CLINICAL TAKEAWAY

For AI-based treatment planning, good dose prediction is not enough if the resulting modulation cannot survive sequencing and TPS recalculation. This work moves automated planning closer to a clinically meaningful endpoint by optimizing for deliverability, but plan quality still remained inferior to the TPS reference and external validation across other techniques and institutions is needed.

SOURCE

Journal of Applied Clinical Medical Physics

Browse more research Suggest a correction